Healthcare >> CEO Interviews >> June 15, 2000
MICHAEL D. KISHBAUCH, OraPharma's President and Chief Executive Officer,
has over 18 years of industry experience. Mr. Kishbauch has had an
impressive record of launching and commercializing products, most
notably during his 11-year career with Ciba-Geigy. As Vice President
and Ciba's Senior Internal Marketing Executive, he oversaw the launches
of Voltaren' and Habitrol', at the time, the two most successful product
launches in industry history as measured by first-year sales of $280
million and $300+ million, respectively. Following his career at Ciba,
Mr. Kishbauch spent several years as President and COO of MedImmune,
Inc., a top-tier biotechnology company focused on infectious disease and
cancer. Mr. Kishbauch began his career with The Procter and Gamble
Company. He received a BA in Biology from Wesleyan University and an MBA
from the Wharton School of the University of Pennsylvania. Profile
Mr. Kishbauch: OraPharma is a company whose goal is to become a leader
in the research, development and marketing of products
